Modulation of human 5-lipoxygenase activity by membrane lipids.
Abhay H Pande, David Moe, Kathleen N Nemec, Shan Qin, Shuhua Tan, Suren A Tatulian
Index: Biochemistry 43(46) , 14653-66, (2004)
Full Text: HTML
Abstract
Mammalian 5-lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) to leukotrienes, potent inflammatory mediators. 5-LO is activated by a Ca(2+)-mediated translocation to membranes, and demonstrates the characteristic features of interfacially activated enzymes, yet the mechanism of membrane binding of 5-LO is not well understood. In an attempt to understand the mechanism of lipid-mediated activation of 5-LO, we have studied the effects of a large set of lipids on human recombinant 5-LO activity, as well as mutual structural effects of 5-LO and membranes. In the presence of 0.35 mM phosphatidylcholine (PC) and 0.2 mM Ca(2+), there was substrate inhibition at >100 microM AA. Data analysis at low AA concentrations yielded the following: K(m) approximately 103 microM and k(cat) approximately 56 s(-1). 5-LO activity was supported by PC more than by any other lipid tested except for a cationic lipid, which was more stimulatory than PC. Binding of 5-LO to zwitterionic and acidic membranes was relatively weak; the extent of binding increased 4-8 times in the presence of Ca(2+), whereas binding to cationic membranes was stronger and essentially Ca(2+)-independent. Polarized attenuated total reflection infrared experiments implied that 5-LO binds to membranes at a defined orientation with the symmetry axis of the putative N-terminal beta-barrel tilted approximately 45 degrees from the membrane normal. Furthermore, membrane binding of 5-LO resulted in dehydration of the membrane surface and was paralleled with stabilization of the structures of both 5-LO and the membrane. Our results provide insight into the understanding of the effects of membrane surface properties on 5-LO-membrane interactions and the interfacial activation of 5-LO.
Related Compounds
Related Articles:
2015-10-01
[Eur. Biophys. J. 44 , 503-12, (2015)]
2010-11-01
[Eur. J. Med. Chem. 45 , 4813-26, (2010)]
1998-06-01
[Cancer Biochem. Biophys. 16(1-2) , 85-110, (1998)]
2000-06-01
[Anal. Biochem. 281(2) , 144-50, (2000)]
2004-12-07
[Langmuir 20(25) , 10858-67, (2004)]